KPTI logo

Karyopharm Therapeutics (KPTI) Company Overview

Profile

Full Name:

Karyopharm Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 6, 2013

Indexes:

Not included

Description:

Karyopharm Therapeutics is a biopharmaceutical company focused on developing innovative treatments for cancer and other serious diseases. They specialize in creating drugs that target the nuclear transport system, aiming to improve patient outcomes and provide new options for difficult-to-treat conditions.

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 19, 2025

Recent annual earnings:

Feb 19, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 20, 25 RBC Capital
Outperform
Feb 20, 25 HC Wainwright & Co.
Buy
Feb 10, 25 RBC Capital
Outperform
Jan 15, 25 HC Wainwright & Co.
Buy
Nov 6, 24 Piper Sandler
Overweight
Nov 6, 24 HC Wainwright & Co.
Buy
Nov 1, 24 HC Wainwright & Co.
Buy
Aug 7, 24 RBC Capital
Outperform
Aug 7, 24 HC Wainwright & Co.
Buy
Aug 7, 24 Baird
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Karyopharm Therapeutics?
  • Does Karyopharm Therapeutics pay dividends?
  • What sector is Karyopharm Therapeutics in?
  • What industry is Karyopharm Therapeutics in?
  • What country is Karyopharm Therapeutics based in?
  • When did Karyopharm Therapeutics go public?
  • Is Karyopharm Therapeutics in the S&P 500?
  • Is Karyopharm Therapeutics in the NASDAQ 100?
  • Is Karyopharm Therapeutics in the Dow Jones?
  • When was Karyopharm Therapeutics's last earnings report?
  • When does Karyopharm Therapeutics report earnings?
  • Should I buy Karyopharm Therapeutics stock now?

What is the ticker symbol for Karyopharm Therapeutics?

The ticker symbol for Karyopharm Therapeutics is NASDAQ:KPTI

Does Karyopharm Therapeutics pay dividends?

No, Karyopharm Therapeutics does not pay dividends

What sector is Karyopharm Therapeutics in?

Karyopharm Therapeutics is in the Healthcare sector

What industry is Karyopharm Therapeutics in?

Karyopharm Therapeutics is in the Biotechnology industry

What country is Karyopharm Therapeutics based in?

Karyopharm Therapeutics is headquartered in United States

When did Karyopharm Therapeutics go public?

Karyopharm Therapeutics's initial public offering (IPO) was on November 6, 2013

Is Karyopharm Therapeutics in the S&P 500?

No, Karyopharm Therapeutics is not included in the S&P 500 index

Is Karyopharm Therapeutics in the NASDAQ 100?

No, Karyopharm Therapeutics is not included in the NASDAQ 100 index

Is Karyopharm Therapeutics in the Dow Jones?

No, Karyopharm Therapeutics is not included in the Dow Jones index

When was Karyopharm Therapeutics's last earnings report?

Karyopharm Therapeutics's most recent earnings report was on Feb 19, 2025

When does Karyopharm Therapeutics report earnings?

The next expected earnings date for Karyopharm Therapeutics is May 8, 2025

Should I buy Karyopharm Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions